Abstract
Although cases of “malignant goitre with amyloid stroma” had already been described by the turn of this century in the German literature (Burk 1901; Jaquet 1906; Stoffel 1910), it is only 30 years since medullary carcinoma of the thyroid (MTC) was first clearly separated from the other types of thyroid carcinoma (Hazard et al. 1959). During the following decade, the classical histological features of MTC were described (Williams et al. 1966), the thyroid C-cell as the cell of origin delineated (Williams 1966), and the link with calcitonin (CT) production demonstrated (Cunliffe et al. 1968; Milhaud et al. 1968). It was, in addition, realized that a proportion of cases of MTC were genetically determined, occurring in association with phaeochromocytoma, or with phaeochromocytoma and multiple mucosal neuromas (Williams 1965; Schimke et al. 1968; Williams and Pollock 1966). Afterwards, the terms multiple endocrine neoplasia (MEN) 2 and MEN 3 were introduced by Steiner et al. (1968) and Khairi et al. (1975), respectively, to distinguish these combinations of tumours from Wermer’s syndrome (parathyroid, pituitary, and endocrine pancreatic tumours), which was given the name MEN 1 as it was described first. MEN 2 has been subsequently subdivided into MEN 2A (which includes MTC, phaeochromocytoma, and hyperparathyroidism) and MEN 2B (which refers to the neuromata syndrome including MTC, phaeochromocytoma, mucosal neuromata, gastrointestinal ganglioneuromatosis and marfanoid habitus) (Chong et al. 1975), and the term MEN 2B is now more commonly used than MEN 3 to designate the neuromata syndrome. The genetic defects leading to the development of familial MTC inherited in the setting of the MEN 2 syndromes are described in detail in R.F. Gagel et al., this volume. The aetiology and concrete pathogenesis of sporadic (non-hereditary) MTC has, in contrast, not yet been elucidated. It is, however, generally accepted that exogenous factors such as hypercalcaemia, hypervitaminoses D and A and irradiation known to be associated with higher incidence of MTC in various mammals are not carcinogenic to human C-cells (Saad et al. 1984a).
Supported by the Deutsche Forschungsgemeinschaft, the Hamburger Krebsgesellschaft and the Hamburger Stiftung zur Förderung der Krebsbekämpfung.
The skilful technical assistance of Mr. Jochen Koppelmeyer in preparing the micrographs is gratefully acknowledged.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achilles E, Padberg BC, Hol1 K, Klöppel G, Schröder S (1991) Immunocytochemistry of paragangliomas — value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology 18: 453–458
Albores-Saavedra J, LiVolsi VA, Williams ED (1985) Medullary carcinoma. Semin Diagn Pathol 2: 137–146
Albores-Saavedra J, Monforte H, Nadji M, Morales AR (1988) C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19: 795–799
Albores-Saavedra J, de la Mora TG, de la Torre-Rendon F, Gould E (1990) Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma. Hum Pathol 21: 1151–1155
Bäckdahl M, Tallroth E, Auer G, Forsslund G, Granberg PO, Lundell G, Löwhagen T (1985) Prognostic value of nuclear DNA content in medullary thyroid carcinoma. World J Surg 9: 980–987
Baylin SB, Mendelsohn G, Weisburger WR, Gann DS, Eggleston JC (1979) Levels of histaminase and L-dopa decarboxylase activity in the transition from C-cell hyperplasia to familial medullary thyroid carcinoma. Cancer 44: 1315–1321
Berger G, Berger N, Guillaud MH, Trouillas J, Vauzelle JL (1988) Calcitonin-like immunoreactivity of amyloid fibrils in medullary thyroid carcinomas. Virchows Arch [A] 412: 543–551
Bergholm U, Adami HO, Auer G, Bergström R, Bäckdahl M, Grimelius L, Hansson G, Ljungberg O, Wilander E (1989) Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. A nationwide study in Sweden. Cancer 64: 135–142
Beskid M (1979) C cell adenoma of the thyroid gland. Oncology 36: 19–22
Biddinger PW, Brennan MF, Rosen PP (1991) Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. Am J Surg Pathol 15: 599–604
Bigner SH, Mendelsohn G, Wells SA, Cox EB, Baylin SB, Eggleston JE (1981) Medullary carcinoma of the thyroid in the multiple endocrine neoplasia IIA syndrome. Am J Surg Pathol 5: 459–472
Burk (1901) Über einen Amyloidtumor mit Metastasen. Dissertation, University of Tübingen
Bussolati G, Monga G (1979) Medullary carcinoma of the thyroid with atypical pattern. Cancer 44: 1769–1777
Capella C, Bordi C, Monga G, Buffa R, Fontana P, Bonfanti S, Bussolati G, Solcia E (1978) Multiple endocrine cell types in thyroid medullary carcinoma. Evidence for calcitonin, somatostatin, ACTH, 5HT and small granule cells. Virchows Arch [A] 377: 111–128
Carney JA (1988) Commentary following Kodama T, Okamoto T, Fujimoto Y, Obara T, Ito Y, Aiba M, Hirayama A C cell adenoma of the thyroid: a rare but distinct clinical entity. Surgery 104: 997–1003
Carney JA, Sizemore GW, Hayles AB (1979) C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2b. Cancer 44: 2173–2183
Carney JA, Ryan J, Goellner JR (1986) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 10: 672–679
Chong GC, Beahrs OH, Sizemore GW, Woolner LH (1975) Medullary carcinoma of the thyroid gland. Cancer 35: 695–704
Cunliffe WJ, Black MM, Hall R, Johnston IDA, Hudgson P, Shuster S, Gudmundsson TV, Joplin GF, Williams ED, Woodhouse NJY, Galante L, Maclntyre I (1968) A calcitonin-secreting thyroid carcinoma. Lancet iî: 63–66
Deftos LJ (1983) Medullary thyroid carcinoma. Karger, Basel DeLellis
RA, Balogh K (1973) Histochemical characteristics of parafollicular cells and medullary thyroid carcinoma. Am J Pathol 72: 119–128
DeLellis RA, Nunnemacher G, Wolfe HJ (1977) C-cell hyperplasia. An ultrastructural analysis. Lab Invest 36: 237–248
DeLellis RA, Rule AH, spiler I, Nathanson L, Tashijan AT, Wolfe HJ (1978) Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 70: 587–594
Didolkar MS, Moore GE (1974) Hormone-dependent medullary carcinoma of the thyroid. Am J Surg 128: 100–103
Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M, Gould E, AlboresSaavedra J (1989) Oxyphil and squamous variants of medullary thyroid carcinoma. Cancer 63: 1183–1188
Driman D, Murray D, Kovacs K, Stefaneanu L, Higgins HP (1991) Encapsulated medullary carcinoma of the thyroid. A morphologic study including immunocytochemistry, electron microscopy, and in situ hybridization. Am J Surg Pathol 15: 1089–1095
Ekman T, Bergholm U, Bäckdahl M, Adami HO, Bergström R, Grimelius L, Auer G, Swedish Medullary Thyroid Cancer Study Group (1990) Nuclear DNA content and survival in medullary thyroid carcinoma. Cancer 65: 511–517
El-Naggar AK, Ordonez NG, McLemore D, Schultz P, Hickey RC, Samaan N (1990) Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma. Surgery 108: 981–985
Emmertsen K (1985) Medullary thyroid carcinoma and calcitonin. Dan Med Bull 32: 1–28
Eusebi V, Damiani S, Riva C, Lloyd RV, Capella C (1990) Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch [A] 417: 267–271
Fernandes BJ, Bedard YC, Rosen I (1982) Mucus-producing medullary cell carcinoma of the thyroid gland. Am J Clin Pathol 78: 536–540
Franc B, Caillou B, Carrier AM, Dutrieux-Berger N, Floquet J, Houcke M, Justrabo E, Lange F, Pages A, Rigaud C, Schwartz A, Viennet M, Lebodic MF (1987) Immunohistochemistry in medullary thyroid carcinoma: prognosis and distinction between hereditary and sporadic tumors. Henry Ford Hosp Med J 35: 139–142
Gibson WGH, Peng T, Croker BP (1982) Age-associated C-cell hyperplasia in the human thyroid. Am J Pathol 106: 388–393
Grün R, Eberle F (1981) Multiple endocrine neoplasia, type II ( MEN II ). Ergeb Inn Med Kinderheilkel 46: 151–201
Haak HR, Cornelisse CJ, Goslings BM, Fleuren GJ (1991) Nuclear DNA content of medullary thyroid carcinoma in a large family with the MEN-2A syndrome. J Endocrinol Invest 14: 261–264
Hales M, Rosenau W, Okerlund MD, Galante M (1982) Carcinoma of the thyroid with a mixed medullary and follicular pattern. Morphologic, immunohistochemical and clinical laboratory study. Cancer 50: 1352–1359
Harach HR, Bergholm U (1988) Medullary ( C-cell) carcinoma of the thyroid with features of follicular oxyphilic cell tumours. Histopathology 13: 645–656
Harach HR, Williams ED (1983) Glandular (tubular and follicular) variants of medullary carcinoma of the thyroid. Histopathology 7: 83–97
Hazard JB, Hawk WA, Crile G (1959) Medullary (solid) carcinoma of the thyroid — a clinicopathologic entity. J Clin Endocrinol Metab 19: 152–161
Hay ID, Ryan JJ, Grant CS, Bergstrahl EJ, van Heerden JA, Goellner JR (1990) Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma. Surgery 108: 972–980
Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumours. Springer, Berlin Heidelberg New York (international histological classification of tumours, no. 11, 2nd edn)
Heitz PU, Steiner H (1981) Pluriglanduläre endokrine Regulationsstörungen. In: Doerr W, Seifert G (eds) Pathologie der endokrinen Organe. Springer, Berlin Heidelberg New York, pp 1137–1203
Hill CS, Ibanez ML, Samaan NA, Ahearn MJ, Clark PL (1973) Medullary (solid) carcinoma of the thyroid gland. An analysis of the M.D. Anderson Hospital experience with patients with the tumor, its special features, and its histogenesis. Medicine (Baltimore) 52: 141–171
Holm R, Sobrinho-Simoes M, Nesland JM, Gould VE, Johannessen JV (1985) Medullary carcinoma of the thyroid gland; an immunocytochemical study. Ultrastruct Pathol 8: 25–41
Holm R, Sobrinho-Simoes M, Nesland JM, Johannessen JV (1986) Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells. Ultrastruct Pathol 10: 241–248
Holm R, Sobrinho-Simoes M, Nesland JM, Sambade C, Johannessen JV (1987) Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity? Lab Invest 57: 258–268
Holm R, Farrants GW, Nesland JM, Sobrinho-Simoes M, Jorgensen OG, Johannessen JV (1989) Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma. Virchows Arch [A] 414: 375–384
Ibanez ML, Cole VW, Russell WO, Clark RL (1967) Solid carcinoma of the thyroid gland. Analysis of 53 cases. Cancer 20: 706–723
Jackson CE, Talpos GB, Kambouris A, Yott JB, Tashjian AH, Block MA (1983) The clinical course after definitive operation for medullary thyroid carcinoma. Surgery 94: 995–1001
Jaquet J (1906) Ein Fall von metastasierenden Amyloidtumoren (Lymphosarkoma). Virchows Arch [A] 185: 251–267
Kakudo K (1990) Subclassification and prognostic factors of medullary (C cell) carcinoma of the thyroid. In: Lechago J, Kameya T (eds) Endocrine pathology update, vol 1. Field and Wood, New York, pp 85–97
Kakudo K, Miyauchi A, Ogihara T, Takai SI, Kitamura H, Kosaki G, Kumahara Y (1978) Medullary carcinoma of the thyroid. Giant cell type. Arch Pathol Lab Med 102: 445–447
Kakudo K, Miyauchi A, Takai S, Katayama S, Kuma K, Kitamura H (1979) C cell carcinoma of the thyroid — papillary type. Acta Pathol Jpn 29: 653–659
Kakudo K, Carney JA, Sizemore GW (1985) Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasms. Cancer 55: 2818–2821
Katoh R, Jasani B, Williams ED (1989) Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology 15: 211–224
Khairi MRA, Dexter RN, Burzynski NJ, Johnston CC (1975) Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: multiple endocrine neoplasia type 3. Medicine (Baltimore) 54: 89–112
Kimura N, Sasano N, Yamada R, Satoh J (1988) Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour,42 S. Schröder et al.
medullary thyroid carcinoma and carcinoid tumour. Virchows Arch [A] 413: 33–38
Kini SR, Miller M, Hamburger JI, Smith MJ (1984) Cytopathologic features of medullary carcinoma of the thyroid. Arch Pathol Lab Med 108: 156–159
Kodama T, Okamoto T, Fujimoto Y, Obara T, Ito Y, Aiba M, Hirayama A (1988) C cell adenoma of the thyroid: a rare but distinct clinical entity. Surgery 104: 997–1003
Krisch K, Krisch I, Horvat G, Neuhold N, Ulrich W (1985) The value of immunohistochemistry in medullary thyroid carcinomas: a systematic study of 30 cases. Histopathology 9: 1077–1089
Lamberg BA, Reissel P, Stenman S, Koivuniemi A, Ekbolm M, Mäkinen J, Franssila K (1981) concurrent medullary and papillary thyroid carcinoma in the same thyroid lobe and in siblings. Acta Med Scand 209: 421–424
Landon G, Ordonez NG (1985) Clear cell variant of medullary carcinoma of the thyroid. Hum Pathol 16: 844–847
Lee TK, Myers RT, Marshall RB, Bond MG, Kardon B (1985) The significance of mitotic rate: a retrospective study of 127 thyroid carcinomas. Hum Pathol 16: 1042–1046
Libbey NP, Nowakowski KJ, Tucci JR (1989) C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto’s thyroiditis. Am J Surg Pathol 13: 71–77
Lippman SM, Mendelsohn G, Trump D, Wells SA, Baylin SB (1982) The prognostic and biological significance of celluar heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab 54: 233–240
Lips CJM, Leo JR, Berends MJH, Minder WH, Blok APR, Geerdink RA, Hackeng WHL, Roelofs JMM, Vasen HFA, Vette JK (1987) Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery. Henry Ford Hosp Med J 35: 133–138
LiVolsi VA (1990) Surgical pathology of the thyroid. Saunders, Philadelphia (Major problems in pathology, vol 22 )
Ljungberg 0 (1972) On medullary carcinoma of the thyroid. Acta Pathol Microbiol Scand [A] Suppl 231
Ljungberg O, Bondeson L, Bondeson AG (1984) Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma. Hum Pathol 15: 218–228
Lloyd RV, Sisson JC, Marangos PJ (1983) Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma. An immunohistochemical study. Cancer 51: 2234–2239
Marcus JN, Dise CA, LiVolsi VA (1982) Melanin production in a medullary thyroid carcinoma. Cancer 49: 2518–2526
Martinelli G, Bazzocchi F, Govoni E, Santini D (1983) Anaplastic type of medullary thyroid carcinoma. An ultrastructural and immunohistochemical study. Virchows Arch [A] 400: 61–67
Mendelsohn G, Oertel JE (1981) Encapsulated medullary thyroid carcinoma. Lab Invest 44: 43A
Mendelsohn G, Bigner SH, Egleston JC, Baylin SB, Wells SA (1980) Anaplastic variants of medullary thyroid carcinoma. Am J Surg Pathol 4: 333–341
Mendelsohn G, Wells SA, Baylin SB (1984) Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized and virulent disseminated stages of disease. Cancer 54: 657–662
Meyer JS, Hutton WE, Kenny AD (1973) Medullary carcinoma of thyroid gland. Subcellular distribution of calcitonin and relationship between granules and amyloid. Cancer 31: 433–441
Miettinen M (1987) Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. Arch Pathol Lab Med 111: 813–818
Milhaud G, Tubiana M, Parmentier C, Coutris G (1968) Epithelioma de la thyroide secretant de la thyrocalcitonine. C R Acad Sci [D] 266: 608–610
Mills SE, Stallings RG, Austin MB (1986) Angiomatoid carcinoma of the thyroid gland. Anaplastic carcinoma with follicular and medullary features mimicking angiosarcoma. Am J Clin Pathol 86: 674–678
Norman T, Johannessen JV, Gautvik KM, Olsen BR, Brennhovd IO (1976) Medullary carcinoma of the thyroid. Diagnostic problems. Cancer 38: 366–377
Norton JA, Froome LC, Farrell RE, Wells SA (1979) Multiple endocrine neoplasia type IIb. The most aggressive form of medullary thyroid carcinoma. Surg Clin North Am 59: 109–118
Pacini F, Basolo F, Elisei R, Fugazzola L, Cola A, Pinchera A (1991) Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. Am J Clin Pathol 95: 300–308
Parker LN, Kollin J, Wu SY, Rypins EB, Juler GL (1985) Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern. Arch Intern Med 145: 1507–1509
Pfaltz M, Hedinger CE, Mühlethaler JP (1983) Mixed medullary and follicular carcinoma of the thyroid. Virchows Arch [A] 400: 53–59
Rasmusson B (1984) Clinical traits in medullary carcinoma of the thyroid. Dan Med Bull 31: 159–164
Reubi JC, Chayvialle JA, Franc B, Cohen R, Calmettes C, Modigliani E (1991) Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 64: 567–573
Rosai J (1989) Thyroid gland. In: Rosai J (ed) Ackerman’s surgical pathology, vol 1, 7th edn. Mosby, St Louis, pp 391–447
Rosenberg-Bourgin M, Gardet P, de Sahb R, Schlumberger M, Caillou B, GuilloudBataille M, Travagli JP, Feingold N, Parmentier C (1989) Comparison of sporadic and hereditary forms of medullary thyroid carcinoma. Henry Ford Hosp Med J 37: 141–143
Rossi RL, Cady B, Meissner WA, Wool MS, Sedgwixck CE, Werber J (1980) Nonfamilial medullary thyroid carcinoma. Am J Surg 139: 554–560
Rougier P, Parmentier C, Laplanche A, Lefevre M, Travagli JP, Caillou B, Schlumberger M, Lacour J, Tubiana M (1983) Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys-9: 161–169
Ruppert JM, Eggleston JC, des Bustros A, Baylin SB (1986) Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor. Am J Surg Pathol 10: 513–518
Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill CS, Hickey RC, Samaan NA (1984a) Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 63: 319–342
Saad MF, Ordonez NG, Guido JJ, Samaan NA (1984b) The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid. J Clin Endocrinol Metab 59: 850–856
Samaan NA, Schultz PN, Hickey RC (1989) Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy. Horm Metab Res Suppl 21: 21–25
Schimke RN, Hartmann WH, Prout TE, Rimoin DL (1968) Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma, and multiple neuromas. N Engl J Med 279: 1–7
Schröder S (1988) Pathologie und Klinik maligner Schilddrüsen-tumoren. Fischer, Stuttgart (Veröffentlichungen aus der Pathologie, vol 130 )
Schröder S, Klöppel G (1987) Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies. Am J Surg Pathol 11: 100–108
Schröder S, Klöppel G (1987) Thyroid antibodies ( Letter ). Am J Surg Pathol 11: 823–824
Schröder S, Dockhorn-Dworniczak B, Kastendieck H, Böcker W, Franke WW (1986) Intermediate-filament expression in thyroid gland carcinomas. Virchows Arch [A] 409: 751–766
Schröder S, Böcker W, Baisch H, Bürk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Klöppel G (1988) Prognostic factors in medullary thyroid carcinomas: survival in relation to age, sex, stage, histology, immunocytochemistry and DNA content. Cancer 62: 806–816
Schröder S, Schwarz W, Rehpenning W, Dralle H, Bay V, Böcker W (1988) Leu-Ml immunoreactivity and prognosis in medullary carcinomas of the thyroid gland. J Cancer Res Clin Oncol 114: 291–296
Schröder S, Bätge B, Padberg B, von Herbay B, Dralle H (1991) Predictive value of histology and immunocytochemistry for radioiodine uptake (RIU) of metastatic and recurrent differentiated thyroid cancer. Acta Endocrinol (Copenh) 124 Suppl 1: 3
Sikri Kl, Varnell IM, Hamid QA, Wilson BS, Kameya T, Ponder BAJ, Lloyd RV, Bloom SR, Polak JM (1985) Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers. Cancer 56: 2481–2491
Simpson WJ, Palmer JA, Rosen IB, Mustard RA (1982) Management of medullary carcinoma of the thyroid. Am J Surg 144: 420–422
Sobrinbo-Simoes M, Nesland JM, Johannessen JV (1985) Farewell to the dual histogenesis of thyroid tumors? Ultrastruct Pathol 8:iii—iv
Sobrinho-Simoes M, Sambade C, Nesland JM, Holm R, Damjanov I (1990) Lectin histochemistry and ultrastructure of medullary carcinoma of the thyroid. Arch Pathol Lab Med 114: 369–375
Steiner AL, Goodman AD, Powers SR (1968) Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism, and Cushing’s disease: MEN, type II. Medicine (Baltimore) 47: 371–409
Stoffel E (1910) Lokales Amyloid der Schilddrüse. Virchows Arch Pathol Anat Physiol 201: 245–252
Takami H, Bessho T, Kameya T, Mimura T, Ito K, Abe O, Hosoda Y, Shikata JI (1988) Immunohistochemical study of medullary thyroid carcinoma: relationship of clinical features to prognostic factors in 36 patients. World J Surg 12: 572–579
Talerman A, Lindeman J, Kievit-Tyson PA, Dröge-Droppert C (1979) Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid ( MCT) by immunoperoxidase technique. Histopathology 3: 503–510
Tanaka T, Yoshimi N, Kanai N, Mori H, Nagai K, Fujii A, Sakata S, Tokimitsu N (1989) Simultaneous occurrence of medullary and follicular carcinoma in the same thyroid lobe. Hum Pathol 20: 83–86
Tennvall J, Björklund A, Möller T, Ranstam J, Akerman M (1985) Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 years. Acta Radiol [Oncol] 24: 17–24
Thompson NW (1984) Commentary following Jackson CE, Talpos GB, Block MA, Norum RA, Lloyd RV, Tashjian AH (1984) Clinical value of tumor doubling estimations in multiple endocrine neoplasia type II. Surgery 96: 981–987
Tubiana M, Milhaud G, Coutris G, Lacour J, Parmentier C, Bok B (1968) Medullary carcinoma and thyrocalcitonin. Br Med J 4: 87–89
Ulbright TM, Kraus FT, O’Neal LW (1981) C-cell hyperplasia developing in residual thyroid following resection of sporadic medullary carcinoma. Cancer 48: 2076–2079
Uribe M, Fenoglio-Preiser CM, Grimes M, Feind C (1985) Medullary carcinoma of the thyroid gland. Clinical, pathological and immunohistochemical features with review of the literature. Am J Surg Pathol 9: 577–594
Westermark P, Johnson KH (1988) The polypeptide hormone derived amyloid forms. Acta Pathol Microbiol Immunol Scand 96: 475–483
Williams ED (1965) A review of 17 cases of carcinoma of the thyroid and phaeochromocytoma. J Clin Pathol 18: 288–292
Williams ED (1966) Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol 19: 114–118
Williams ED (1985) Medullary carcinoma of the thyroid. In: Polak JM, Bloom SR (eds) Endocrine tumours. Churchill Livingstone, Edinburgh, pp 229–240
Williams ED (1986) Immunocytochemistry in the diagnosis of thyroid disease. In: Polak JM, van Noorden S (eds) Immunocytochemistry. Modern methods and applications, 2nd edn. Wright, Bristol, pp 533–546
Williams ED, Pollock DJ (1966) Multiple mucosal neuromata with endocrine tumours. A syndrome allied to von Recklinghausen’s disease. J Pathol Bacteriol 91: 71–80
Williams ED, Brown CL, Doniach I (1966) Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol 19: 103–113
Wilson NW, Pambakian H, Richardson TC, Stokoe MR, Makin CA, Heyderman E (1986) Epithelial markers in thyroid carcinoma: an immunoperoxidase study. Histopathology 10: 815–829
Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, Al Saadi AA, Juliar JF, Jackson CE, Tashjian AH (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289: 437–441
Wolfe HJ, DeLellis RA, Jackson CE, Greenawald KA, Block MA, Tashjian AH (1980) Immunocytochemical distinction of hereditary from sporadic medullary thyroid carcinoma. Lab Invest 42: 161–162
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Schröder, S., Holl, K., Padberg, B.C. (1992). Pathology of Sporadic and Hereditary Medullary Thyroid Carcinoma. In: Raue, F. (eds) Medullary Thyroid Carcinoma. Recent Results in Cancer Research, vol 125. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84749-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-84749-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84751-6
Online ISBN: 978-3-642-84749-3
eBook Packages: Springer Book Archive